title: Time-concentration profile of serum etanercept in Japanese patients with rheumatoid arthritis after treatment discontinuation before orthopedic surgery.
authors.affiliation: Department of Human Morphology, Science of Functional Recovery and Reconstruction, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, Okayama, 700-8558, Japan. knishida@md.okayama-u.ac.jp
authors.forename: Keiichiro
authors.initials: K
authors.lastname: Nishida
authors.forename: Kenzo
authors.initials: K
authors.lastname: Hashizume
authors.forename: Yasutaka
authors.initials: Y
authors.lastname: Kadota
authors.forename: Masamitsu
authors.initials: M
authors.lastname: Natsumeda
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Nakahara
authors.forename: Taichi
authors.initials: T
authors.lastname: Saito
authors.forename: Tomoko
authors.initials: T
authors.lastname: Kanazawa
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Ezawa
authors.forename: Toshihumi
authors.initials: T
authors.lastname: Ozaki
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000097:blood / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D057234:Preoperative Period; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood; D013997:Time Factors; D028761:Withholding Treatment
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept